Opus Genetics (IRD) Return on Capital Employed Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -13,073.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,073.00 |
| Dec 31, 2025 | -17,182.00 |
| Sep 30, 2025 | -62,119.00 |
| Jun 30, 2025 | -14,195.00 |
| Mar 31, 2025 | -23,231.00 |
| Dec 31, 2024 | -11,789.00 |
| Sep 30, 2024 | 6,093.00 |
| Jun 30, 2024 | 14,279.00 |
| Mar 31, 2024 | 15,224.00 |
| Dec 31, 2023 | 17,712.00 |
| Sep 30, 2023 | 7,898.00 |
| Jun 30, 2023 | 6,289.00 |
| Mar 31, 2023 | 10,702.00 |
| Dec 31, 2022 | -37,325.00 |
| Sep 30, 2022 | -5,710.00 |
| Jun 30, 2022 | -2,688.00 |
| Mar 31, 2022 | 238.00 |
| Dec 31, 2021 | 6,472.00 |